# Chongqing Daxin Pharmaceutical Co., Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/chongqing-daxin-pharmaceutical-co-ltd/41f80e0d-c994-41e7-aa3f-32c2aabcea04

> Inspection records and compliance data for Chongqing Daxin Pharmaceutical Co., Ltd. in Beibei, None. Access full analysis and detailed observations.

---

## Details

- Name: Chongqing Daxin Pharmaceutical Co., Ltd.
- FEI Number: 3000291692
- City: Beibei
- State: None
- Country Name: China
- Address Line 1: No. 21 Founder Road, Shuituzhen
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [483 - Chongqing Daxin Pharmaceutical Co., Ltd. - Unknown Date](https://www.keypedia.com/records/483/chongqing-daxin-pharmaceutical-co-ltd/5d609919-e31b-46ca-9028-820353b31a8b) — source: FDA, date: Invalid Date
- [483 - Chongqing Daxin Pharmaceutical Co., Ltd. - 2024-06-28](https://www.keypedia.com/records/483/chongqing-daxin-pharmaceutical-co-ltd/307e313b-3e1a-4cce-a698-75b4070f514a) — source: FDA, date: June 28, 2024
- [FDA Inspection 1245029 - Chongqing Daxin Pharmaceutical Co., Ltd. - 2024-06-28](https://www.keypedia.com/records/fda_inspections/chongqing-daxin-pharmaceutical-co-ltd/9d9c682d-2383-480f-8b01-ae1b51e3e370) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 28, 2024
- [483 - Chongqing Daxin Pharmaceutical Co., Ltd. - 2018-05-11](https://www.keypedia.com/records/483/chongqing-daxin-pharmaceutical-co-ltd/3e60e0c3-3216-42e0-96c2-f610faa4b0b0) — source: FDA, date: May 11, 2018
- [FDA Inspection 1056109 - Chongqing Daxin Pharmaceutical Co., Ltd. - 2018-05-11](https://www.keypedia.com/records/fda_inspections/chongqing-daxin-pharmaceutical-co-ltd/cda74d6b-05ac-44c9-a971-2273e84327b9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 11, 2018
- [FDA Inspection 912081 - Chongqing Daxin Pharmaceutical Co., Ltd. - 2015-01-29](https://www.keypedia.com/records/fda_inspections/chongqing-daxin-pharmaceutical-co-ltd/978947b5-3c24-4523-8c63-4ce4f89716b1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2015

## Related Companies

- [Zhejiang Tianyu Pharmaceutical Co. Ltd.](https://www.keypedia.com/companies/zhejiang-tianyu-pharmaceutical-co-ltd/b7ecf3cd-082c-48b5-94e1-8adeba7ce167)
- [Sri Krishna Pharmaceuticals Limited](https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-limited/5afbb0e4-2595-4bfc-8ecd-7c0d9deb8b38)
- [Centrient Pharmaceuticals India Private Limited](https://www.keypedia.com/companies/centrient-pharmaceuticals-india-private-limited/cb4cf503-2578-4e8f-b226-d736e975468e)
- [Kumar Organic Products Limited](https://www.keypedia.com/companies/kumar-organic-products-limited/07ad463c-e67e-4f49-a181-5a89e435be26)
- [Hubei JXBio Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/hubei-jxbio-pharmaceutical-co-ltd/0cb70a5f-908f-45e1-bf50-87d4e83281b5)
- [Taenaka Kogyo Co., Ltd.](https://www.keypedia.com/companies/taenaka-kogyo-co-ltd/81821784-e9ae-463f-9ab9-29a5c7605880)
- [Jiangsu NHWA Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/jiangsu-nhwa-pharmaceutical-co-ltd/7b3402dc-1e72-471c-ba50-33f225ac6625)
- [Flamma USA LLC](https://www.keypedia.com/companies/flamma-usa-llc/e8b09d1a-f37b-4e4b-bff0-dc0533ac62f3)
- [Shanghai Kyowa Amino Acid Co., Ltd.](https://www.keypedia.com/companies/shanghai-kyowa-amino-acid-co-ltd/597fd21a-b509-43d8-bbec-88c4fdcccbf7)
- [Goodwin Biotechnology, Inc.](https://www.keypedia.com/companies/goodwin-biotechnology-inc/ecf6d534-aaa3-4d43-b900-12cc1172cc90)

## Related Officers

- [Joni D. Hustrot](https://www.keypedia.com/people/joni-d-hustrot/b7c40cdf-d1e3-459b-afd0-af4e78d04da2)
- [issuing_officer](https://www.keypedia.com/people/gavin-t-cua/6f498dd6-2c4b-42e9-8ddc-3c2a7c97afef)
- [company_representative](https://www.keypedia.com/people/maria-t-bradfish/3e002ea4-0b63-45b8-9ded-fb31909dc059)